[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359225-105":59,"doc-detail-359225-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","nanomedicine-leverages-cuproptosis-mediated-cgas-sting-activation-to-enhance-antitumor-immunity","Nanomedicine leverages cuproptosis-mediated cGAS-STING activation to enhance antitumor immunity","","The cGAS-STING pathway is a central innate-immunity axis that senses cytosolic DNA and triggers type I interferons and inflammatory signaling. Direct clinical use of conventional STING agonists is limited by poor pharmacokinetics, insufficient tumor specificity, and systemic toxicity. Emerging evidence links cGAS-STING activation with cuproptosis, a copper-dependent mitochondrial cell-death program. Nanomedicine can exploit this synergy by inducing cuproptosis in tumor cells, releasing mitochondrial DNA that activates cGAS-STING, amplifying interferons and pro-inflammatory cytokines to reshape the tumor microenvironment and strengthen systemic antitumor immunity; the review summarizes signaling, recent nanomedicine strategies, and future challenges.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nanomedicine-leverages-cuproptosis-mediated-cgas-sting-activation-to-enhance-antitumor-immunity/359225/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nanomedicine-leverages-cuproptosis-mediated-cgas-sting-activation-to-enhance-antitumor-immunity/359225.png","ImageObject",300,407,{"name":92,"@type":93},"Rhys","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is cGAS-STING activation important for antitumor immunity?","Question",{"text":113,"@type":114},"cGAS-STING senses cytosolic DNA and initiates type I interferon and inflammatory responses, which can promote dendritic cell maturation, antigen presentation, and cytotoxic T-cell infiltration while counteracting immunosuppression in tumors.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What restricts the clinical translation of conventional STING agonists?",{"text":118,"@type":114},"Conventional STING agonists face poor pharmacokinetics, rapid systemic clearance, limited tumor specificity, and dose-limiting systemic toxicities.",{"name":120,"@type":111,"acceptedAnswer":121},"How does cuproptosis connect to cGAS-STING in the proposed nanomedicine strategy?",{"text":122,"@type":114},"Engineered nanoplatforms induce cuproptosis in tumor cells, causing mitochondrial damage and release of mitochondrial DNA into the cytosol, where it acts as an endogenous ligand to activate the cGAS-STING pathway and trigger a strong downstream cytokine cascade.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},359225,1790173300,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Li etal. Journal of Nanobiotechnology (2026) 24:271  \n[https://doi.org/10.1186/s12951-026-04203-w](https://doi.org/10.1186/s12951-026-04203-w)  \nJournal of Nanobiotechnology  \nREVIEW Open Access  \nNanomedicine leverages cuproptosis- mediated cGAS-STING activation to enhance antitumor immunity  \nChunfei Li1†, Yunze Li1†, Zhiji Wang2, Yumin Wang3, Wenzheng Guan4* and Zhe Huang1*  \nAbstract  \nThe cGAS-STING pathway is a cornerstone of innate immunity, sensing cytosolic DNA to initiate potent type I interferon and inflammatory responses. Its targeted activation represents a promising strategy to overcome cancer immunosuppression and resistance. However, the clinical translation of conventional STING agonists is hindered by poor pharmacokinetics, lack of tumor specificity, and systemic toxicity. Recent advances highlight a crucial interaction between the cGAS-STING pathway and cuproptosis, a novel copper-dependent form of regulated  \ncell death driven by mitochondrial metabolism. Nanomedicine offers a transformative platform for exploiting this synergy. Specifically, engineered nanoplatforms can induce cuproptosis within tumor cells, leading to mitochondrial damage and the release of mitochondrial DNA (mtDNA) into the cytosol. This released mtDNA serves as a potent endogenous ligand to activate the cGAS-STING pathway. The subsequent cascade results in robust production of type I interferons and pro-inflammatory cytokines, which remodel the tumor microenvironment by promoting dendritic cell maturation, macrophage repolarization, and cytotoxic T-cell infiltration. This bridges a unique immunogenic cell death mechanism with the activation of systemic antitumor immunity. This review outlines the cGAS-STING signaling axis and its role in cancer, details the functional interplay with cuproptosis, and focuses on recent nanomedicine strategies designed to leverage this cuproptosis–mtDNA –cGAS-STING axis to potentiate antitumor immunity. We further discuss current challenges and future perspectives for this innovative combinatorial immunotherapy approach. Overall, this article highlights promising nanomedicine-based avenues that leverage the cGAS-STING–cuproptosis interplay for cancer therapy.  \nKeywords Cancer drug resistance, Antitumor immunity, cGAS-STING, Cuproptosis, Nanomedicine  \n†Chunfei Li and Yunze Li contributed equally to this work.  \n*Correspondence: Wenzheng Guan [cmuwzguan@163.com](cmuwzguan@163.com)[ ](cmuwzguan@163.com)Zhe Huang [huangzhe928@163.com](huangzhe928@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nLi et al. Journal of Nanobiotechnology (2026) 24:271 Page 2 of 32  \nGraphical Abstract  \nIntroduction  \nThe immune system plays a critical role in surveilling and eliminating malignant cells, a process fundamental for antitumor immunity. Harnessing this intrin","cbCaio1TqaQxR4I4","https://ap.wps.com/l/cbCaio1TqaQxR4I4","pdf",11019265,32,"English","# Abstract\n## Introduction\n## cGAS-STING pathway in cancer\n## Challenges of conventional STING agonists\n## Nanomedicine strategies to enhance delivery and activity\n## Cuproptosis–mtDNA–cGAS-STING axis and immunogenic remodeling\n## Current challenges and future perspectives","[{\"question\":\"Why is cGAS-STING activation important for antitumor immunity?\",\"answer\":\"cGAS-STING senses cytosolic DNA and initiates type I interferon and inflammatory responses, which can promote dendritic cell maturation, antigen presentation, and cytotoxic T-cell infiltration while counteracting immunosuppression in tumors.\"},{\"question\":\"What restricts the clinical translation of conventional STING agonists?\",\"answer\":\"Conventional STING agonists face poor pharmacokinetics, rapid systemic clearance, limited tumor specificity, and dose-limiting systemic toxicities.\"},{\"question\":\"How does cuproptosis connect to cGAS-STING in the proposed nanomedicine strategy?\",\"answer\":\"Engineered nanoplatforms induce cuproptosis in tumor cells, causing mitochondrial damage and release of mitochondrial DNA into the cytosol, where it acts as an endogenous ligand to activate the cGAS-STING pathway and trigger a strong downstream cytokine cascade.\"}]","Nanomedicine leverages cuproptosis-mediated cGAS-STING activation to enhance antitumor immunity | PDF",1790136464,81,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df75a942a79c0181a0a5ce22265665ab.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6c483dab2c5c1707e9e52787a746e16.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f70ac871ae0c1345b3f4963a00496ff5.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2f9cdc2db0134e562b6b57ea4176737.webp",980,1306]